The global Rhizoma Gastrodiae tablets market is experiencing significant growth, driven by increasing consumer preference for plant-based and traditional medicines, rising prevalence of chronic diseases, and expanding research and development activities. Projected to reach a market size of USD 1.2 billion by 2032, the industry is expected to grow at a compound annual growth rate (CAGR) of 5.48% from 2024 to 2032 .

Market Drivers

1.     Growing Demand for Herbal Medicines: Traditional herbal medicines are gaining traction globally. The World Health Organization (WHO) notes that traditional herbal medicine was effectively used to treat severe acute respiratory syndrome (SARS) in China, and 80% of Africans utilize various forms of herbal medicine . This trend underscores a broader shift towards natural remedies, bolstering the demand for Rhizoma Gastrodiae tablets.

2.     Prevalence of Liver Disorders: Liver diseases account for approximately 2 million deaths annually worldwide, with significant contributions from cirrhosis, viral hepatitis, and hepatocellular carcinoma . The therapeutic properties of Rhizoma Gastrodiae tablets make them a promising alternative for managing liver-related ailments, thereby driving market growth.

3.     Increased Research and Development: Intensified research efforts are exploring the benefits and applications of Rhizoma Gastrodiae. Scientific validation of its efficacy in treating various ailments enhances consumer trust and opens new avenues for therapeutic uses .

Regional Insights

• China: As the epicenter of Traditional Chinese Medicine (TCM), China is expected to generate over 50% of the global Rhizoma Gastrodiae tablets market revenue. The integration of TCM into the healthcare system and the presence of numerous regional manufacturers contribute to this dominance .
• India: India is projected to exhibit a robust 9% CAGR in the Rhizoma Gastrodiae tablets market. With a significant number of practitioners in traditional medicine systems like Ayurveda, the country presents substantial growth opportunities
• United States: The U.S. market is anticipated to expand at under 5% CAGR until 2031, driven by increasing preference for herbal medicines. Sales of herbal products in the U.S. have shown consistent growth, indicating a favorable environment for Rhizoma Gastrodiae tablets .

Market Segmentation

• By Type: Gastrodia elata f. glauca Rhizoma Gastrodiae tablets are highly preferred, expected to witness an impressive 10% CAGR until 2031. These tablets are effective in treating conditions such as headaches, dizziness, convulsions, and rheumatism
• By Distribution Channel: Retail pharmacies are projected to account for maximum sales, expanding at a CAGR of approximately 15%. Online pharmacies are also gaining traction, with sales expected to expand at under 5% CAGR until 2031

Competitive Landscape

The Rhizoma Gastrodiae tablets market is highly consolidated, with major players primarily based in China. Notable companies include Guangzhou Pharmaceutical Holdings, Tianjin Jiarui Pharmaceutical, Jiangsu Province Pharmaceutical, Sinopharm Chemical Reagent, and Beijing Tongrentang

Challenges

1.     Limited Global Manufacturing: Currently, the bulk of Rhizoma Gastrodiae tablets production is concentrated in China, limiting global availability. Efforts are underway by certain players to expand their presence in overseas markets .

2.     Regulatory Hurdles: Due to limited literature on the efficacy of Rhizoma Gastrodiae tablets, regulatory approvals can be challenging, delaying product launches in new markets .

3.     High Production Costs: The extraction process of gastrodin, the active compound in Rhizoma Gastrodiae, is complex and expensive, leading to higher costs for consumers and potentially limiting adoption, especially in developing countries .

 Future Outlook

The Rhizoma Gastrodiae tablets market is poised for continued growth, driven by increasing consumer awareness, expanding research, and the global shift towards natural and traditional medicines. Addressing manufacturing and regulatory challenges will be crucial for unlocking the market's full potential.

Explore More Related Studies Published by Fact.MR Research:

The circular polymers market is valued at USD 88.52 billion in 2025. As per Fact.MR analysis, it will grow at a CAGR of 10.41% and reach USD 238.96 billion by 2035.

The global dental 3D printing market is valued at US$ 3 billion in 2023 and is projected to exhibit expansion at a phenomenal 22% CAGR over the next ten years to reach US$ 21.9 billion by the end of 2033.

The global silver enamel market was estimated to be worth around US$ 2 Billion by 2021. With the increasing usage of Silver Enamel for several reasons worldwide, the market is expected to reach a worth of about US$ 3.6 Billion by the end of 2032, with a projected CAGR of 5.3% during 2022 to 2032. From 2015 to 2021, the Silver Enamel Market experienced a growth of 5.9%.

The global composites testing market is valued at USD 2.0 billion in 2025. As per Fact.MR analysis, it will grow at a CAGR of 5.2% and reach USD 3.9 billion by 2035.

The global acetone derivatives market stands at US$ 11.2 billion in 2022 and is forecasted to progress steadily at a CAGR of 5.8% to reach a market valuation of US$ 19.9 billion by the end of 2032.

The global revenue from the sales of biofuels in 2021 was US$ 140.43 Billion. The industry is likely to expand at a CAGR of 4.8% during 2022 to 2032.

At present, global demand for earthmoving equipment tyres is valued at US$ 13 billion and is expected to increase at 4.2% CAGR from 2023 to 2033. By the end of 2033, the global earthmoving equipment tyres market is forecasted to attain a valuation of US$ 19.7 billion.

About Fact.MR:

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.

Contact:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog